Total | NoTEs | TEs | PTSD | Group comparison | ||
---|---|---|---|---|---|---|
Test statistic | p-value | |||||
N (female) | 111 (48) | 31 (5) | 42 (20) | 38 (23) | X2(2) = 14.2 | <0 .001a |
Age (SD) | 16.0 (1.3) | 16.0 (1.3) | 16.0 (1.2) | 16.1 (1.3) | F(108) = 0.8 | 0.923 |
N with substance use disorders (%) | X2 (3) = 2.9 | 0.816 | ||||
Alcohol | 45 (40.5%) | 11 (35.5%) | 18 (42.9%) | 16 (42.1%) | ||
Cannabis | 58 (52.3%) | 15 (48.4%) | 24 (57.1%) | 19 (50.0%) | ||
MDMA | 26 (23.4%) | 4 (13.0%) | 11 (26.2%) | 11 (29.0%) | ||
Stimulants | 25 (23.4%) | 3 (9.7%) | 12 (28.6%) | 8 (21.1%) | ||
N with psychotic disorders (%) | 4 (3%) | 0 | 1 (2%) | 3 (8%) | X2 (2) = 3.4 | 0.187 |
N with anxiety disorders (%) | 20 (18%) | 2 (6%) | 4 (10%) | 14 (37%) | X2 (2) = 14.0 | < .001a |
N with mood disorders (%) | 62 (56%) | 15 (48%) | 20 (48%) | 27 (71%) | X2 (2) = 5.4 | 0.067 |
N with behavioural disorders (%) | 57 (51%) | 13 (42%) | 19 (45%) | 11 (29%) | X2 (2) = 2.2 | 0.341 |
N with obsessive–compulsive disorder (%) | 5 (5%) | 0 | 0 | 5 (13%) | X2 (2) = 10.1 | 0.007a |